UPDATE : Monday, December 16, 2019
상단여백
AMC unravels clues in treating relapsing, metastatic bladder cancer
Asan Medical Center researchers have clarified the pathogenesis of cancer s...
by Lee Han-soo  |  2019-12-06 18:22
라인
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
Gemvax & Kael said that it presented the results of phase 2 clinical trial ...
by Lee Han-soo  |  2019-12-06 17:06
라인
AbbVie’s Venclexta nears insurance benefit
AbbVie Korea’s Venclexta Tab. (ingredient: venetoclax), a drug for recurren...
by Kim Eun-young  |  2019-12-06 16:35
라인
Syntekabio, CHA Hospital to co-develop immunotherapy
Syntekabio said that it will develop immunotherapy agents jointly with CHA ...
by Lee Han-soo  |  2019-12-06 16:32
라인
Medpacto vows to become global company specializing in biomarker-based drugs
Medpacto, a subsidiary of Theregen ETEX, plans to develop Vactosertib, an i...
by Lee Han-soo  |  2019-12-06 15:03
라인
Petitioner demands broader benefit for ovarian cancer drug Zejula
The government granted insurance benefit to Takeda's ovarian cancer tre...
by Song Soo-youn  |  2019-12-06 15:02
라인
China OKs Humedix's hyaluronic acid filler
Humedix said that China's National Medical Products Administration (NMP...
by Lee Han-soo  |  2019-12-06 15:02
라인
Foreign trainee doctors to get easier extension of training
Foreign doctors receiving training at local medical institutions will find ...
by Kwak Sung-sun  |  2019-12-06 12:42
라인
‘Endogenous T cells have high potential of treating blood, solid tumors’
A variety of adoptive T-cell therapeutic strategies has shown a remarkable ...
by Lee Han-soo  |  2019-12-06 12:41
라인
Korea exports health insurance system to Bahrain
The Korean government has completed establishing a health insurance system ...
by Kwak Sung-sun  |  2019-12-05 16:12
라인
‘Lynparza raises value of precision medicine as anticancer treatment’
AstraZeneca’s Lynparza (ingredient: olaparib), the first PARP (poly ADP rib...
by Kim Yun-mi  |  2019-12-05 16:05
라인
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports
Celltrion Healthcare said that it has become the first local biopharmaceuti...
by Lee Han-soo  |  2019-12-05 15:04
라인
Roche Diabetes Care stresses ‘integrated personalized diabetes management’
Roche Diabetes Care emphasized the importance of “integrated personalized d...
by Park Gi-taek  |  2019-12-05 13:01
라인
Macrogen’s research on Asian genomic database becomes cover story of Nature
Macrogen said that it presented the result of its Asian genome analysis, wh...
by Lee Han-soo  |  2019-12-05 11:54
라인
‘Obesity treatment will drastically change next few years’
An Irish expert on obesity and diabetes said Wednesday that prospects for t...
by Lee Han-soo  |  2019-12-04 18:20
라인
'Insulin is safe, natural replacement therapy for diabetic patients'
In Korea, 20.9 percent of diabetic patients, who have a hemoglobin A1c (HbA...
by Lee Han-soo  |  2019-12-04 17:07
라인
SK Biopharm set to ensure superiority in antiepileptic drug
SK Biopharmaceuticals said it would begin to develop a second new drug for ...
by Jeong Sae-im  |  2019-12-04 16:18
라인
Hanmi licenses in US firm’s oral immunotherapy candidate
Hanmi Pharmaceutical said that it has licensed in FLX475, the world’s first...
by Lee Han-soo  |  2019-12-04 16:16
라인
ISU Abxis starts trial of Gaucher disease treatment in Australia
ISU Abxis said that it has started phase 1 clinical trial of Abcertin, an e...
by Lee Han-soo  |  2019-12-04 16:16
라인
Korean patient with rare breast cancer to sue Allergan in US
A Korean patient who developed rare cancer after receiving Allergan’s speci...
by Song Soo-youn  |  2019-12-04 14:49
여백
여백
여백
Back to Top